Peter R. Carroll

106.1k citations

880 papers · 46.0k indexed · 17 hit papers · h-index 110

Impact in

Pulmonary and Respiratory Medicine top 0.01%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Urology top 0.02%
- Urological Disorders and Treatments

Papers in

Pulmonary and Respiratory Medicine 647
- Prostate Cancer Diagnosis and Treatment 542
- Prostate Cancer Treatment and Research 509
Urology 72
- Urological Disorders and Treatments 41

Co-authors: Matthew R. Cooperberg Deborah P. Lubeck Janet E. Cowan Jeanette M. Broering Gary D. Grossfeld Katsuto Shinohara Hedvig Hricak John Kurhanewicz
Journals: The Journal of Urology (288 papers)Urology (69 papers)Journal of Clinical Oncology (66 papers)European Urology (40 papers)Cancer (36 papers)
Partner nations: United States Canada Germany

In The Last Decade

Peter R. Carroll

862 papers receiving 44.7k citations

Hit Papers

15 papers align trajectories log scale

Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states 2022 · 140 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Communications
2021 Clinical Cancer Research
2021 The Journal of Urology
2018 European Urology
2016 JAMA Oncology
2015 JAMA
2014 European Urology
2014 European Urology
2012 European Urology
2012 European Urology
2012 European Urology
2011 Cancer
2010 Journal of Clinical Oncology
2009 The Journal of Urology
2008 The Lancet Oncology
2005 The Journal of Urology
1993 PubMed

Peers

Countries citing papers authored by Peter R. Carroll

Since Specialization

Citations

This map shows the geographic impact of Peter R. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Carroll more than expected).

Fields of papers citing papers by Peter R. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Carroll. The network helps show where Peter R. Carroll may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter R. Carroll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter R. Carroll Line = papers co-authored together Peter R. Carroll links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Delphi Consensus Project on Prostate-specific Membrane Antigen (PSMA)-Targeted Surgery – outcomes from an international multidisciplinary panel European Urology Open Science ·B Zhang, Wm.G. Hinson, Tobias Maurer, Katharina Hermann, Freddie C. Hamdy, Sophie Knipper, Paolo Dell’Oglio, Elio Mazzone, Hilda A. de Barros, Jonathan Sorger, Matthias N. van Oosterom, Phillip D. Stricker, Pim J. van Leeuwen, Daphne D. D. Rietbergen, R.A. Valdés Olmos, Sergi Vidal‐Sicart, Peter R. Carroll, Tessa Buckle, Henk G. van der Poel, Fijs W. B. van Leeuwen	2023	2
2	Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer Histopathology ·Nancy Greenland, Janet E. Cowan, Bradley A. Stohr, Jeffry Simko, Peter R. Carroll, Emily Chan	2023	5
3	Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial European Urology Oncology ·Erin L. Van Blarigan, Stacey A. Kenfield, Adam B. Olshen, Peter Haselbauer, Amir Faraji, Imelda Tenggara, Rebecca E. Graff, Christine Enfield, Katsuto Shinohara, Matthew R. Cooperberg, Peter R. Carroll, Lee W. Jones, Kerri M. Winters‐Stone, Anthony Luke, June M. Chan	2023	9
4	Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality British Journal of Cancer ·Crystal S. Langlais, Rebecca E. Graff, Erin L. Van Blarigan, John Neuhaus, Janet E. Cowan, Jeanette M. Broering, Peter R. Carroll, Stacey A. Kenfield, June M. Chan	2023	4
5	Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality Cancer Epidemiology Biomarkers & Prevention ·Crystal S. Langlais, Rebecca E. Graff, Erin L. Van Blarigan, Stacey A. Kenfield, John Neuhaus, Fred K. Tabung, Janet E. Cowan, Jeanette M. Broering, Peter R. Carroll, June M. Chan	2022	15
6	Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study Clinical Cancer Research ·Michael J. Morris, Steven P. Rowe, Michael A. Gorin, Lawrence Saperstein, Frédéric Pouliot, David Josephson, Jeffrey Y.C. Wong, Austin R. Pantel, Steve Y. Cho, Kenneth L. Gage, Morand Piert, Andrei Iagaru, Janet H. Pollard, Vivien Wong, Jessica Jensen, Tess Lin, Nancy Stambler, Peter R. Carroll, Barry A. Siegel Hit paper breakdown →	2021	237
7	Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial European Urology Open Science ·Justin Ferdinandus, Wolfgang P. Fendler, Jérémie Calais, Hicran Yıldız Şimşek, Robert R. Flavell, Ashley Mishoe, Akiko Ota, Hao G. Nguyen, Robert E. Reiter, Matthew B. Rettig, J Gartmann, 實濱口, Eric J. Small, Roger Slavik, Peter R. Carroll, Karin A. Herrmann, Johannes Czernin, Thomas A. Hope	2020	2
8	Clinical utility of biomarkers 4K score, SelectMDx and ExoDx with MRI for the detection of high-grade prostate cancer European Urology Open Science ·Vittorio Fasulo, Laurentiu Diaconu, Elizabeth J. Ryan, Annika Herlemann, 彦右衛門前川, Arupratan Santra, Walter Robert I., Alberto Saita, Matthew R. Cooperberg, Kentaro Shinohara, Peter R. Carroll, Hao G. Nguyen	2020	0
9	Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy European Urology Oncology ·Vittorio Fasulo, Janet E. Cowan, Martina Maggi, Samuel L. Washington, Hao G. Nguyen, Katsuto Shinohara, Massimo Lazzeri, Paolo Casale, Peter R. Carroll	2020	5
10	Active Surveillance in Younger Men With Prostate Cancer Journal of Clinical Oncology ·Michael S. Leapman, Janet E. Cowan, Hao G. Nguyen, Katsuto Shinohara, Nannette Perez, Matthew R. Cooperberg, William J. Catàlona, Peter R. Carroll	2017	36
11	Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations Cancer Epidemiology Biomarkers & Prevention ·Michael B. Cook, Frank Z. Stanczyk, Shannon N. Wood, Ruth M. Pfeiffer, M. Ch. Fermond, Akbar Wijaya, Soraida Vásquez Nova, Roni T. Falk, Cindy Ke Zhou, Shelley Niwa, SHIMAA KHALF ALLAH, Yu-Tang Gao, George P. Hemstreet, Ella I. Altman, Peter R. Carroll, Michael J. Manyak, Miyazaki Mitsuyuki, Paul H. Levine, Ann W. Hsing	2017	12
12	Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer Cancer Immunology Research ·Xiao X. Wei, Pat Hopkins, Serena S. Kwek, Jera Lewis, Vinh Dao, Li Zhang, Matthew R. Cooperberg, Charles J. Ryan, Amy Lin, Terence W. Friedlander, Brian Rini, Christopher Kane, Jeffry Simko, Peter R. Carroll, Eric J. Small, Lawrence Fong	2016	30
13	Overdetection of Recurrence after Radical Prostatectomy: Estimates Based on Patient and Tumor Characteristics Clinical Cancer Research ·Jing Xia, Bruce J. Trock, Roman Gulati, Leslie Mallinger, Matthew R. Cooperberg, Peter R. Carroll, Laurent Hsia, Ruth Etzioni	2014	13
14	Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study Clinical Cancer Research ·Daniel W. Lin, Lisa F. Newcomb, Elissa C. Brown, James D. Brooks, Peter R. Carroll, Ziding Feng, Martin Gleave, Raymond S. Lance, Martin G. Sanda, Ian M. Thompson, John T. Wei, Peter S. Nelson, (unknown)	2013	111
15	Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort Journal of Clinical Oncology ·Matthew R. Cooperberg, Jeffry Simko, Janet E. Cowan, Julia Reid, Azita Djalilvand, S. K. Bhatnagar, Alexander Gutin, Jerry S. Lanchbury, Gregory P. Swanson, Steven Stone, Peter R. Carroll	2013	260
16	Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance Journal of Clinical Oncology ·Sima P. Porten, Jared M. Whitson, Janet E. Cowan, Matthew R. Cooperberg, Katsuto Shinohara, Nannette Perez, Kirsten L. Greene, Maxwell V. Meng, Peter R. Carroll	2011	149
17	Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer Journal of Clinical Oncology ·Matthew R. Cooperberg, Janet E. Cowan, Joan F. Hilton, Adam C. Reese, Harras B. Zaid, Sima P. Porten, Katsuto Shinohara, Maxwell V. Meng, Kirsten L. Greene, Peter R. Carroll	2010	219
18	Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients Cancer Research ·Felix Moltzahn, Adam B. Olshen, Lauren Baehner, Andrew S. Peek, Lawrence Fong, Hubert Stöppler, Jeffry Simko, Joan F. Hilton, Peter R. Carroll, Robert Blelloch	2010	274
19	A Group of Genome-Based Biomarkers That Add to a Kattan Nomogram for Predicting Progression in Men with High-Risk Prostate Cancer Clinical Cancer Research ·Pamela L. Paris, Vivian Weinberg, Giancarlo Albo, Ritu Roy, Catherine Burke, Jeffry Simko, Peter R. Carroll, Colin C. Collins	2009	25
20	Bladder Cancer Outcome and Subtype Classification by Gene Expression Clinical Cancer Research ·Ekaterini Blaveri, Jeff Simko, James E. Korkola, Jeremy L. Brewer, Frederick L. Baehner, Kshama Mehta, Sandy DeVries, Theresa M. Koppie, Sunanda Pejavar, Peter R. Carroll, Frederic M. Waldman	2005	275

About Peter R. Carroll

Peter R. Carroll is a scholar working on Pulmonary and Respiratory Medicine, Urology, Rheumatology, Oncology and Statistics and Probability, having authored 880 papers that have together received 46.0k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (542 papers), Prostate Cancer Treatment and Research (509 papers), Bladder and Urothelial Cancer Treatments (158 papers), Urologic and reproductive health conditions (100 papers), Global Cancer Incidence and Screening (51 papers), Statistical Methods in Clinical Trials (46 papers), Cancer, Lipids, and Metabolism (41 papers) and Urological Disorders and Treatments (41 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (30.7k citations), Urology (4.1k citations), Rheumatology (6.2k citations), Cancer Research (5.6k citations) and Radiology, Nuclear Medicine and Imaging (6.5k citations). Peter R. Carroll has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Matthew R. Cooperberg, Deborah P. Lubeck, Janet E. Cowan, Jeanette M. Broering, Gary D. Grossfeld, Katsuto Shinohara, Hedvig Hricak, John Kurhanewicz, Maxwell V. Meng and June M. Chan. Their work appears in journals such as The Journal of Urology, Urology, Journal of Clinical Oncology, European Urology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact